Quantification of left atrial contractile function using two-dimensional speckle tracking echocardiography in horses after conversion of atrial fibrillation to sinus rhythm by Eberhardt, Christina & Schwarzwald, Colin C








Quantification of left atrial contractile function using two-dimensional
speckle tracking echocardiography in horses after conversion of atrial
fibrillation to sinus rhythm
Eberhardt, Christina ; Schwarzwald, Colin C
Abstract: Introduction/objectives: In horses, persistent atrial dysfunction is a prognostic indicator of
recurrence of atrial fibrillation (AF). The objective of this study was to quantify left atrial (LA) contrac-
tile function in Warmblood horses after successful cardioversion of AF to sinus rhythm, using standard
two-dimensional echocardiography (2DE) and two-dimensional speckle tracking (2DST) analyses, and
to provide proof-of-concept for use of 2DST to detect LA contractile dysfunction in horses. Animals,
materials, and methods: Nineteen Warmblood horses with AF and successful transvenous electrical
cardioversion (TVEC) or medical cardioversion using quinidine sulfate (QS) were included. Echocardio-
graphy was performed at 24 hr, 72 hr, and 1-6 months after cardioversion. Conventional 2DE-derived
indices of LA size and function and global longitudinal strain (SL) and longitudinal strain rate (SRL)
during LA contractile function were measured to detect differences in LA size and function over time and
between treatment modalities. The association between 2DE-derived indices and global SL and SRL,
respectively, and the agreement of the variables to detect LA dysfunction were assessed. Results: Global
SL and SRL, as well as active LA fractional area change (FAC) identified cases with LA dysfunction
after TVEC and QS cardioversion and proved useful to demonstrate LA functional recovery over time.
Agreement between active LA FAC and SL and SRL, respectively, to diagnose atrial dysfunction was
substantial to fair at 24 hr after cardioversion and decreased with time. Conclusion: This study shows
that 2DST is useful to quantify LA contractile dysfunction in horses after cardioversion of AF.
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Abstract Introduction/Objectives: In horses, persistent atrial dysfunction is a
prognostic indicator of recurrence of atrial fibrillation (AF). The objective of this
study was to quantify left atrial (LA) contractile function in Warmblood horses after
successful cardioversion of AF to sinus rhythm, using standard two-dimensional
echocardiography (2DE) and two-dimensional speckle tracking (2DST) analyses,
and to provide proof-of-concept for use of 2DST to detect LA contractile dysfunc-
tion in horses.
Animals, materials, and methods: Nineteen Warmblood horses with AF and suc-
cessful transvenous electrical cardioversion (TVEC) or medical cardioversion using
quinidine sulfate (QS) were included. Echocardiography was performed at 24 hr,
72 hr, and 1e6 months after cardioversion. Conventional 2DE-derived indices of
LA size and function and global longitudinal strain (SL) and longitudinal strain rate
(SRL) during LA contractile function were measured to detect differences in LA size
and function over time and between treatment modalities. The association be-
tween 2DE-derived indices and global SL and SRL, respectively, and the agreement
of the variables to detect LA dysfunction were assessed.
Results: Global SL and SRL, as well as active LA fractional area change (FAC) iden-
tified cases with LA dysfunction after TVEC and QS cardioversion and proved useful
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to demonstrate LA functional recovery over time. Agreement between active LA
FAC and SL and SRL, respectively, to diagnose atrial dysfunction was substantial
to fair at 24 hr after cardioversion and decreased with time.
Conclusion: This study shows that 2DST is useful to quantify LA contractile dysfunc-
tion in horses after cardioversion of AF.
ª 2021 The Authors. Published by Elsevier B.V. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Introduction
Atrial fibrillation (AF) is the most common
arrhythmia in horses affecting performance. In the
equine athlete, AF commonly exists in the absence
of any clinically relevant underlying structural
cardiac disease, although microstructural lesions
or channelopathies predisposing to AF might be
present in some of these horses [1]. Once sus-
tained, AF itself causes time-dependent electrical,
functional, and structural remodeling within the
atria, which favor perpetuation of the arrhythmia
[2,3]. Pre-existing microstructural alterations and
AF-induced myocardial remodeling within the atria
may hamper cardioversion of sustained AF to nor-
mal sinus rhythm (NSR) and can cause atrial con-
tractile dysfunction, termed atrial stunning, after
successful cardioversion [4,5]. Recovery of left
atrial (LA) contractile function and reverse
remodeling after cardioversion may take days to
several weeks until full function is regained. Per-
sistent atrial dysfunction indicates irreversible
atrial remodeling and might represent a poor
prognostic sign [2].
Follow-up echocardiographic examinations are
useful to monitor atrial contractile function within
the first days and weeks after cardioversion [4,6].
The methods for assessment of LA mechanical
function using two-dimensional echocardiography
(2DE) and tissue Doppler imaging have been
described [4,7e9] and decreased active LA frac-
tional area change (FAC) at 24 hr after car-
dioversion was shown to predict recurrence of AF
[10]. However, the most accurate, reliable, and
clinically most useful methods to assess atrial
contractile dysfunction and the risk of recurrent
AF after cardioversion are yet to be determined.
Two-dimensional speckle tracking (2DST) echo-
cardiography has been shown to be a feasible and
reliable quantitative ultrasound technique for
assessment of LA mechanical function in healthy
people [11e13]. In healthy horses, 2DST has been
used to characterize systolic radial, circum-
ferential, and longitudinal motion of the left and
right ventricle [9,14e16]. Furthermore, 2DST has
been applied to assess ventricular function in
horses with myocardial disease [17e19]. Recently,
we showed that 2DST-based LA wall motion anal-
ysis is a feasible and reliable method for quanti-
fication of global mechanical LA function and we
reported reference intervals for LA global longi-
tudinal strain (SL) and strain rate (SRL) in healthy
Warmblood horses [20].
Two-dimensional speckle tracking-derived LA SL
has been demonstrated to be a useful index in
diagnosis, prognostication and follow-up of AF in
people [21] and several studies showed that LA SL
is a powerful predictor of recurrence of AF
[22e24]. Therefore, 2DST might represent a
promising supplemental technique to aid in the
clinical assessment of LA function in horses with
AF after successful cardioversion to NSR.
The aim of this study was to provide proof-of-
concept for use of 2DST to detect compromised LA
contractile function (booster pump function) in
Warmblood horses after successful cardioversion
of AF to NSR. We hypothesized that 2DST-derived









FAC fractional area change
HR heart rate or heart rates
hr hours
k kappa
LA left atrium or left atrial
LAA left atrial area
LAD left atrial diameter
NSR normal sinus rhythm
QS quinidine sulfate
SL longitudinal strain
SRL longitudinal strain rate
TVEC transvenous electrical cardioversion
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indicating LA contractile dysfunction, and pro-
gressively increase within 72 hr and 1e6 months
after cardioversion.
Animals, material and methods
Study sample
The study sample comprised Warmblood horses
that were diagnosed with AF and presented to the
Clinic for Equine Internal Medicine of the Vetsuisse
Faculty, University of Zurich, Switzerland between
2007 and 2019 for cardioversion. Characteristics of
the study sample are summarized in Table 1.
Atrial fibrillation was diagnosed based on a
surface electrocardiogram (ECG) recording.
Standard two-dimensional (2D) and Doppler echo-
cardiography served to rule out severe underlying
structural cardiac disease before treatment.
Horses included in this study were successfully
treated by means of pharmacological quinidine
sulfate (QS) cardioversion or transvenous electrical
cardioversion (TVEC) and remained in sinus rhythm
for at least 1 month after cardioversion. Complete
echocardiographic examinations were performed
in all horses at 24 hr and 72 hr after cardioversion.
When possible, recheck examination including a
surface ECG recording and a complete echo-
cardiographic examination was performed
between 1 and 6 months after cardioversion at the
Clinic for Equine Internal Medicine of the Vetsuisse
Faculty. Horses that did not present for recheck
examination were followed-up on phone calls with
referring veterinarians to confirm persistence of
NSR; no follow-up ECG and echocardiogram was
possible in these cases.
Echocardiography and 2DST analyses
Horses were unsedated but restrained by an
experienced handler in a quiet room for the
examination. Echocardiographic examinations
were performed using a GE Vivid 7 echocardio-
graph with a M4S probe set at a frequency of 1.5/
3.6 MHz (octave harmonics) or a GE Vivid e95
echocardiograph with a 4Vc-D probe operated in
2D mode and set at a frequency of 1.4/2.8 MHza.
The imaging depth was kept at 30 cm, and the
sector width was reduced to achieve a recording
frame rate of 50e60 frames/s in 2D mode. A single
lead base-apex ECG was recorded simultaneously
for timing purposes. A minimum of three repre-
sentative recordings including three cardiac cycles
each were recorded in each view and stored as
cine-loops in digital raw data format for offline
analyses. Start and end of the cardiac cycle were
defined by the QRS complex. Cycles immediately
after a premature beat, a sinus pause, or a 2nd
Table 1 General characteristics of the study sample.
Variable TVEC group QS group
n 11 8 (10)a
Signalement
Breed Warmblood Warmblood
Sex 7 male, 4 female 7 male, 1 female
Age (mean, range) 11.8 (7e24) years 12.6 (6e19) years
BWT (mean, range) 591 (485e730) kg 615 (540e700) kg
Duration of AF <1 month (n ¼ 2), 1e3 months (n ¼ 3),
>3 months (n ¼ 3), unknown (n ¼ 3)
<1 month (n ¼ 7), 1e3 months (n ¼ 1),
unknown (n ¼ 2)
Time in NSR after
cardioversion
1e3 months (n ¼ 3), 3 months to 1 year
(n ¼ 5), >1 year (n ¼ 3)
<1 year (n ¼ 1), >1 year (n ¼ 8),
unknown (n ¼ 1)
Treatment Number of shocks (median, range):
5 (1e14)
Energy of converting shock (median,
range):
200 (100e360) Joule
Quinidine dose: 22 mg/kg PO q2h (max. 4
doses), then continued q6h




Sotalol (n ¼ 5), sotalol þ quinapril
(n ¼ 4), none (n ¼ 2)
Sotalol þ quinapril (n ¼ 1), quinapril
(n ¼ 2), none (n ¼ 7)
AF, atrial fibrillation; BWT, body weight; n, number; NSR, normal sinus rhythm; PO, per os; QS, quinidine sulfate; TVEC, trans-
venous electrical cardioversion.
a 10 QS cardioversions in 8 horses.
a GE Healthcare, Glattbrugg, Switzerland.
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degree atrioventricular block were precluded from
analyses.
Routine transthoracic 2D, M-mode, color Dop-
pler and tissue Doppler echocardiography were
performed according to a standardized protocol to
assess cardiac structures, valvular competence,
chamber dimensions, and left ventricular systolic
and diastolic function by use of standard right and
left-parasternal long-axis and short-axis views [9].
The LA was imaged in right and left-parasternal
four-chamber views, optimized to obtain an
image of the entire atrium at its maximal
dimensions.
Previously described echocardiographic variables
were measured to characterize LA size and function
[4,7e9]. Dimensional measurements included: Internal
LA diameter measured at the widest distance parallel
to the mitral valve annulus at the time of maximum
atrial filling (i.e. one frame before mitral valve open-
ing; LADmax), internal LA area measured at maximum
atrial filling (LAAmax), at the onset of active atrial
contraction (i.e. at the onset of the electrocardio-
graphic P wave; LAAa), and at minimum atrial filling
(i.e. at the time of closure of the mitral valve; LAAmin)
on a right-parasternal four-chamber view optimized to
image the entire LA; internal area of the LA during
maximum atrial filling (i.e. one frame after the closure
of the aortic valve) on a right-parasternal short-axis
view of the LA and the aorta (LAAsx-max); LA diameter
measured at the widest distance during maximum
atrial filling on a left-parasternal long-axis view opti-
mized to image the LA (LADllx-max). These measure-
ments were corrected for differences in body weight
(BWT) using the following equations: diameter
(500) ¼ measured diameter/BWT1/3  5001/3; area
(500) ¼ measured area/BWT2/3  5002/3. The active
FAC of the LA was calculated as: active LA FAC (%) ¼
(LAAa e LAAmin)/LAAa x 100.
Two-dimensional speckle tracking analysis was
performed offline on the digitally stored cine-loop
recordings of the LA using the ‘Q-Analysis’ module
of the EchoPAC softwareb as described previously
[20]. The 2DST analyses were performed on the
appropriate right-parasternal long-axis view focus-
ing on the LA. The start and the end of the cardiac
cycle was defined by the onset of the P wave (P
wave trigger) on the simultaneously recorded ECG.
Global SL and global SRL were measured during the
period of active LA contraction (booster pump
phase), as the distance from zero baseline to the
first most negative SL and SRL peak, respectively,
just before mitral valve closure (Fig. 1). All
measurements were made in triplicates (measure-
ment of three non-consecutive cycles) and averages
were used for further analyses.
Data analysis and statistics
All statistical and graphical analyses were per-
formed by standard computer softwarec. To detect
the effect of treatment modality (TVEC and QS)
and time point (24 hr, 72 hr and recheck exami-
nation) on heart rate (HR), on 2DE-derived indices
of LA size and function and on 2DST-derived
measurements for LA booster pump function
(global SL and global SRL), a two-way mixed-model
ANOVA with Holm-Sidak post hoc test was per-
formed. Homogeneity of variances was assessed by
graphical display of the data and validity of the
normality assumption was confirmed by assess-
ment of normal probability plots of the residuals.
To assess the association between global SL and
global SRL, respectively, and 2DE-derived indices
of LA size and function, multiple linear regression
was performed; repeated measures over time in
the same horse and treatment effects were
accounted for using dummy variables (effects
coding). Appropriateness of the linear model was
assessed by graphical display of the data and
assessment of normal probability plots of the
residuals.
Cohen’s kappa statistics were performed using
GraphPad QuickCalcsd to quantify agreement of
global SL and SRL, respectively, with active LA FAC
on the diagnosis of atrial dysfunction at the three
different time points (24 hr, 72 hr and recheck
examination) after cardioversion; for this purpose,
atrial dysfunction was defined as a value below the
reference intervals described for active LA FAC [8],
SL, and SRL [20]. Thereby, k was interpreted as
follows: 0.81e1.0, almost perfect agreement;
0.61e0.80, substantial agreement; 0.41e0.60,
moderate agreement; 0.21e0.40, fair agreement;
0.01e0.20, slight agreement; 0, no agreement
[25]. The overall significance level was defined as
p < 0.05.
Results
Eleven successful transvenous electrical car-
dioversions (TVEC group) were performed in 11
b Echopac, version 201, GE Healthcare, Glattbrugg,
Switzerland.
c SigmaPlot 12.3, Systat Software Inc., San Jose, California,
USA.
d GraphPad Software, Online calculator, www.graphpad.com/
quickcalcs, San Diego, California, USA.
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Warmblood horses and ten successful pharmaco-
logical cardioversions with QS (QS group) were
performed in eight Warmblood horses. One horse
had three successful QS cardioversions performed
because of two recurrences of AF; for the purpose
of this proof-of-concept study, these were counted
as individual cases.
Echocardiographic data were available for all 21
cases at 24 hr and 72 hr after cardioversion, and
for 16 cases that were presented to the clinic for a
recheck examination at 1 month (13 cases), 2
months (one case), 4 months (one case), and 6
months (one case) after cardioversion. Four cases
were followed-up by phone call with the referring
veterinarians to ensure that they were still in NSR
1 month after cardioversion, and one case was lost
for follow-up.
The HR ranged between 28 and 49/min in all
horses at all time points. No significant differences
were detected between the TVEC group and the
QS group (p ¼ 0.578; difference of means [95%
confidence interval (CI)]: 1 [-3 to þ2]/min).
However, the HR decreased significantly between
24 hr and 72 hr after cardioversion (p < 0.001; 5
[-2 to 7]/min) and between 24 hr after car-
dioversion and the recheck examination
(p < 0.001; 7 [-4 to 9]/min); no significant
difference was detected between 72 hr after
cardioversion and the recheck examination
(p ¼ 0.164; 2 [1 to 5/min]).
Conventional LA area and diameter measure-
ments of the study sample after cardioversion are
summarized in Fig. 2. Most horses had normal or
enlarged LA dimensions 24 hr after cardioversion.
No significant differences were detected between
the TVEC group and the QS group at any time
point. A significant difference between time
points, independent of treatment group, was only
detected for LAAsx-max between 72 hr and the
recheck examination after cardioversion.
Indices of LA function are summarized in Fig. 3.
Based on active LA FAC, nine out of 11 cases in the
TVEC group and seven out of ten cases in the QS
group were diagnosed with atrial mechanical dys-
function at 24 hr after cardioversion (Fig. 3A). No
significant differences between treatment groups
were detected at any time point. Independent of
treatment group, significant increase in active LA
FAC was detected over time.
Based on global SL, atrial contractile dysfunc-
tion at 24 hr after cardioversion was diagnosed in
nine out of 11 horses in the TVEC group and four
out of ten horses in the QS group (Fig. 3B). Sig-
nificant differences between treatment groups
were not detected at any time point. Global SL
increased significantly (i.e. became more
Figure 1 Two-dimensional speckle tracking analysis of the left atrium (LA). Representative trace screens of (A)
global longitudinal strain (SL) and (B) global longitudinal strain rate (SRL) throughout the cardiac cycle are shown. Top
left, two-dimensional image with the segmented region of interest and parametric color coding; Bottom left, color M-
mode with parametric color coding; Right, dotted lines represent global SL (A) and global SRL (B) at three different
time points (24 hr, 72 hr and 1e6 months re-check) in the same horse. An electrocardiogram is plotted for timing
purposes. The yellow line marks the onset of the P wave (P wave trigger). Ppump: Global SL and global SRL during LA
mechanical function (booster pump function) measured as the distance from zero baseline to the first most negative
peak, respectively, just before mitral valve closure.
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negative) over time, with all cases within the ref-
erence range at the recheck examination.
Global longitudinal strain rate identified six out of
11 cases in the TVEC group and three out of ten cases
in the QS group with atrial contractile dysfunction at
24 hr after cardioversion (Fig. 3C). There was no
significant difference at 24 hr after cardioversion
between treatment groups, but at 72 hr after car-
dioversion and at the recheck examination SRL was
significantly lower (i.e. less negative) in the TVEC
group compared to the QS group. Increase in SRL (i.e.
becomingmore negative) within the TVEC group was
significant between 24 hr and the recheck exami-
nation, as well as 72 hr and the recheck examination
but not between 24 hr and 72 hr. A significant
increase in SRL within the QS group was detected
between all time points. Based on global SRL, all
horses had low-normal atrial function at time of
recheck examination.
Multiple linear regression analyses revealed that
global SL and SRL were significantly associated with
active LA FAC (Table 2) but not to any of the
indices of LA size.
Agreement between global SL and active LA FAC
for the diagnosis of atrial dysfunction was sub-
stantial at 24 hr after cardioversion (k ¼ 0.674;
95% CI, 0.350 to 0.997), fair at 72 hr after car-
dioversion (k ¼ 0.364; 95% CI: 0.018 to 0.710), and
absent at time of recheck examination (k ¼ 0.000;
95% CI: 0.000 to 0.000). Agreement between
global SRL and active LA FAC was fair at 24 hr
(k ¼ 0.323; 95% CI: 0.051 to 0.594) and 72 hr after
cardioversion (k ¼ 0.364; 95% CI: 0.018 to 0.710)
and slight at time of recheck examination
(k ¼ 0.177; 95% CI: 0.144 to 0.499) (Fig. 4).
Discussion
The results of this study show that 2DST echo-
cardiography is a feasible technique to assess LA
Fig.1 2 Scatter dot plot of conventional two-dimensional echocardiography derived variables of left atrial (LA) size
for the two treatment groups (transvenous electrical cardioversion, solid circles; quinidine sulfate, open triangles) at
three different time points (24 hr, 72 hr and 1e6 months recheck) after successful cardioversion. The dotted lines
represent the upper and lower level of the reference interval [8]. Mean values are indicated by horizontal lines. Data
points represent single measurements. LAAmax: Internal LA area measured during maximum atrial filling on a right-
parasternal long-axis view; LAAsx-max: Internal area of the LA during maximum atrial filling on a right-parasternal
short-axis view; LADllx-max: LA diameter measured at the widest distance during maximum atrial filling on a left-
parasternal long-axis view; LADmax: Internal LA diameter measured at the widest distance parallel to the mitral
valve annulus during maximum atrial filling on a right-parasternal long-axis view. All measurements were scaled to a
body weight of 500 kg.
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contractile function in horses with AF after car-
dioversion to NSR. Furthermore, this study con-
firms previous findings of reverse functional
remodeling and shows that in addition to active LA
FAC, global SL and SRL are useful variables to
diagnose atrial dysfunction after cardioversion of
AF and detect recovery thereof over time.
Two-dimensional echocardiographic indices of
atrial mechanical function have previously been
described in horses [7,8] and active LA FAC has
been used in several studies to detect atrial dys-
function in horses after cardioversion of AF to NSR
over time [4e6]. However, 2DE-derived active LA
FAC is not a direct measurement of LA function but
rather represents a calculated index from two
static LA area measurements. Those indices rep-
resent 2D measurements of a complex three-
dimensional structure which do not necessarily
reflect true atrial size. In the literature, there is no
consensus regarding the indices used to calculate
active LA FAC. While in the present study, active LA
FAC was calculated from LAAa (area at onset of
active atrial contraction, e.g. onset of P wave) and
LAAmin (area at mitral valve closure) as described
previously [4,7,8], others have used a different
definition for LAAmin, namely subjectively smallest
LA area at maximal active atrial contraction [10].
This measurement possesses a potentially greater
measurement variability, as the frame of minimal
atrial area has to be selected subjectively. Fur-
thermore, in cases with marked atrial stunning
(i.e., severely diminished or absent atrial con-
traction) the definition of this measurement pre-
cludes accurate measurement. Measurement of
LAAmin at mitral valve closure is clearly defined,
reducing measurement variability. However, it may
not represent true minimal LA dimension as mitral
valve closure is associated with LA relaxation.
Furthermore, 2DE-derived variables of LA mechan-
ical function, including active LA FAC, were shown
to have moderate intraobserver and interobserver
within- and between days variability [7].
Fig. 3 Scatter dot plot of conventional two-
dimensional echocardiography derived active left atrial
fractional area change (active LA FAC) and two-
dimensional speckle tracking (2DST) derived global lon-
gitudinal strain and strain rate for the two treatment
groups (transvenous electrical cardioversion, solid cir-
cles; quinidine sulfate, open triangles) at three different
time points (24 hr, 72 hr and 1e6 months recheck) after
successful cardioversion. The dotted lines represent the
upper and lower level of the reference interval [8,20].
Mean values are indicated by horizontal lines. Data
points represent single measurements. For detailed
explanation of 2DST-derived variables see Fig. 1.
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Table 2 Multiple linear regression analyses. Association between global longitudinal strain and longitudinal strain
rate and two-dimensional echocardiography derived indices of left atrial size and function.
Variable Global longitudinal strain (SL) Global longitudinal strain rate (SRL)
n R2 Adj R2 p n R2 Adj R2 p
LADmax (500) 58 0.668 0.474 0.429 58 0.772 0.639 0.605
LAAmax (500) 58 0.662 0.465 0.891 58 0.771 0.637 0.820
LAAsx-max (500) 57 0.688 0.501 0.111 57 0.792 0.668 0.068
LADllx-max (500) 53 0.647 0.426 0.907 53 0.766 0.619 0.550
Active LA FAC 58 0.834 0.737 <0.001 58 0.893 0.830 <0.001
Active LA FAC, active left atrial fractional area change; Adj R2, adjusted R square; LA, left atrium or left atrial; LAAmax, maximum
LA area in right-parasternal long-axis view; LAAsx-max, maximum LA area in right-parasternal short-axis view; LADllx-max, maximum
LA diameter in left-parasternal long-axis view; LADmax, maximum LA diameter in right-parasternal long-axis view; SL, longitudinal
strain; SRL, longitudinal strain rate; (500), allometrically scaled to a body weight of 500 kg.
Fig. 4 Method agreement for active left atrial fractional area change (LA FAC) with global longitudinal strain (SL,
left panel) and global longitudinal strain rate (SRL, right panel) to diagnose atrial dysfunction at three different time
points (A and B: 24 hr C and D: 72 hr; E and F: 1e6 months re-check). The dots represent individual cases. The dotted
lines represent the upper and lower limit of the reference intervals for the respective variable [8,20]. CI: Confidence
interval; k: Kappa. For detailed explanation of variables see Figs. 1 and 3.
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Analysis of myocardial wall motion is a useful
technique for assessment of myocardial function.
Two-dimensional speckle tracking echocardiog-
raphy allows for objective and quantitative eval-
uation of segmental and global myocardial
velocities, strain, and strain rate. It is angle-
independent, does not require high recording
frame rates, and is relatively independent of the
‘tethering effect’ compared with tissue Doppler
imaging [26]. Tissue Doppler imaging measures
focal wall motion velocity toward or away from the
transducer and calculates strain and strain rate at
this particular point in the myocardium [27]. As
opposed to 2DST, it is highly angle dependent,
influenced by translational motion, and does not
easily allow quantitative assessment of segmental
or global LA wall motion. In man, conventional
echocardiographic indices proved reliable to assess
LA function in a clinical setting, but 2DST-derived
variables have now become widely used to assess
atrial function in a variety of cardiac diseases
[28e31]. Left atrial SL, for example, has been
demonstrated to be a useful complementary index
in diagnosis, prognostication, and follow-up of AF
in people [21].
Assessment of LA function by 2DST may also
become a useful addition to conventional imaging
techniques in veterinary medicine. Speckle track-
ing echocardiography of the LA was found to be
useful in differentiating stages of myxomatous
mitral valve disease in dogs [32,33] and atrial
function was assessed by LA SL in a canine model of
chronic AF and heart failure [34]. Peak atrial lon-
gitudinal strain was found to be a univariate pre-
dictor of cardiac-related death in dogs with
myxomatous mitral valve disease [35].
However, to date, there is no gold standard set
of 2DST variables to describe LA mechanical
function [36]. Left atrial strain and strain rate
curve patterns differ based on the chosen trigger
(P wave or R wave trigger), resulting in different
2DST measurements and normal reference values.
The curve profile of the P wave trigger method
with the corresponding peak variables more
closely represents myocardial deformation from
the atrial perspective and is the preferred method
over the R wave trigger for 2DST analyses of the LA
for subjects in sinus rhythm [37]. Recently, we
reported the use of segmental and global meas-
urements to quantify LA myocardial wall motion in
healthy Warmblood horses using a P wave trigger.
We found that global SL and SRL measurements
have considerably lower intra- and interobserver
measurement variability in comparison to seg-
mental measurements [20]. Therefore, we con-
cluded that global 2DST variables are more likely
to be clinically applicable and may prove useful for
assessment of LA mechanical function in horses
with heart disease. Short- and long-term atrial
dysfunction in horses after cardioversion have
been demonstrated, and reverse remodeling after
cardioversion may take a few days to several
weeks depending on AF duration [4e6]. Because LA
enlargement and atrial dysfunction in horses after
cardioversion of AF are associated with increased
risk of recurrence of AF [10,38], and because vig-
orous exercise and high atrial pressures and
stretch are triggers for AF [39,40], the recom-
mendations in regards to aftercare for successful
cardioversion of AF include short- and long-term
echocardiographic follow-up examinations to
monitor atrial recovery after cardioversion.
Assessment of atrial function after cardioversion
can aid in reducing the required resting period
while allowing adequate time for reverse atrial
remodeling [1,2]. However, the most accurate,
reliable, and clinically most useful methods are
yet to be determined.
In this study, echocardiographic examinations
where performed at 24 hr, 72 hr and 1e6 months
after cardioversion to test the performance of SL
and SRL to diagnose atrial mechanical dysfunction
and early recovery of atrial contractile function,
and to follow-up horses with long-term atrial
stunning. Similar time points had been used in
previous studies to demonstrate short-term and
long-term improvement of atrial function after
cardioversion of AF by 2DE [4,6]. Atrial dysfunction
24 hr after cardioversion was detected in 16 out of
21 horses by 2DE-derived active LA FAC, and in 13
of 21 and nine of 21 horses by 2DST-derived LA
global SL and SRL, respectively. Active LA FAC was
significantly associated with SL and SRL. Also, we
found a substantial agreement between active LA
FAC and global SL, and a fair agreement between
active LA FAC and global SRL for diagnosis of atrial
dysfunction 24 hr after cardioversion. This finding
confirms the hypothesis that 2DST-derived global
SL and SRL are commonly low at 24 hr, are there-
fore useful to detect LA contractile dysfunction,
and can be used complementary to 2DE indices.
Although, an overall short-term improvement of
atrial function was detected, only few cases
recovered to full extent by 72 hr based on 2DE and
2DST variables. This is in line with other studies
that indicate that most cases even with short
duration of AF require several days for reverse
remodeling [5].
While all cases were hospitalized for 3 days
after cardioversion which allowed for the 24 hr and
72 hr examination, only 16 of 21 cases presented
for their follow-up examination. The preferred
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follow-up time point in the authors’ institution is 1
month, however three cases within the QS group
could only be followed-up at later time points (2e6
months). While this represents a limitation in
regard to analysis of long-term recovery of atrial
function, for the purpose of this proof-of-concept
study, one recheck examination group including all
cases independent of exact time point was
formed. A significant long-term improvement of
atrial function was found by means of global SL and
SRL, as well as active LA FAC. This finding shows
that the course of atrial dysfunction and the
recovery thereof can be tracked not only by 2DE
but also by 2DST variables.
Agreement on the diagnosis of atrial dysfunction
between 2DE and 2DST variables decreased with
time point. While there was substantial to fair
agreement in the short-term follow-up, agreement
at the time of re-check examination was slight
between active LA FAC and SRL, and there was no
agreement between active LA FAC and SL. Based
on SL and SRL, atrial function had normalized in all
cases (i.e. measurements were within the refer-
ence range) at time of recheck examination, while
seven cases where diagnosed with persistent atrial
stunning based on active LA FAC. Another study
that investigated long-term atrial function based
on echocardiographic data found that most horses
had normal atrial function 7 weeks after car-
dioversion [6].
For the purpose of this study, atrial dysfunction
was defined as a value below the respective ref-
erence range [8,20]. Most cases diagnosed with
atrial dysfunction at 24 hr after cardioversion had
pronounced atrial dysfunction (i.e. considerably
lower than the lower limit of the reference range),
which made the diagnosis of atrial dysfunction
evident. With improvement of atrial function over
time, more single values were recorded closer to
the lower limit of normal. At time of the recheck
examination, several cases with a value below the
lower reference range for active LA FAC, had very
low-normal SL and SRL values. This must be taken
into consideration when interpreting the results.
Atrial SL has very high sensitivity in identifying
increased atrial stiffness and fibrosis, and there-
fore dysfunction, in man with AF [41]. Because of
its accuracy to quantify myocardial deformation, it
is suggested to be used in addition to conventional
variables to aid in prognostication and follow-up of
patients [21]. Because of the low sample size and
the lack of a gold standard for the diagnosis of
atrial dysfunction, no inference can be made
whether SL or SRL have a higher or lower sensitivity
to detect long-term atrial stunning compared to
conventional variables in horses after successful
treatment of AF. Lacking sufficiently accurate data
regarding time in NSR after successful car-
dioversion, it was not the scope of this study to
investigate the ability of SL and SRL to predict the
recurrence of AF after conversion of AF to NSR.
Therefore, we suggest using 2DST-derived SL and
SRL complementary to conventional variables for
the assessment of atrial dysfunction in horses.
Future studies, including more cases with long-
term follow-up, will need to define the prog-
nostic value for SL and SRL to predict the risk of AF
recurrence. The respective cutoff values for SL and
SRL will certainly be different from the limits of
the reference intervals that were used to define
atrial dysfunction in this proof-of-concept study.
The results of this study indicate that 2DST
measurements of atrial dysfunction and improve-
ment of atrial function over time are not markedly
influenced by treatment method. Horses in this
study were either treated by means of TVEC (11
cases) or medically using QS (ten cases). Atrial
dysfunction occurs with all modes of car-
dioversion, including spontaneous conversion,
however, some studies in other species have
demonstrated that electrical cardioversion causes
prolonged and more severe LA dysfunction [42,43].
In this study, no significant difference in atrial
dysfunction between treatment groups was iden-
tified at any time point for active LA FAC and SL.
However, there was a significant difference in the
rate of atrial myocardial deformation at 72 hr and
the follow-up examination between treatment
groups. Horses that were treated with QS had sig-
nificantly higher SRL (i.e. more negative) than
horses treated with TVEC. However, treatment
method was not randomized in this study but
largely reflected the clinicians’ preference. In
general, QS treatment was more often used in
patients with short duration AF, while TVEC was
more often used in cases with long duration AF or
in cases where previous QS treatment had failed
[2,44e46]. In addition, the small number of horses
and the inclusion of one horse with two AF recur-
rences as separate cases represent limitations
regarding this result. Therefore, conclusions on
the influence of treatment modality on the degree
of atrial dysfunction and recovery thereof cannot
be drawn. Left atrial size might influence atrial
function. However, there was no significant dif-
ference of LA size between treatment groups at
any time point that would have influenced this
result. Overall, there was no significant change in
LA size over time using three of four described
measurements for LA size. Other studies in horses
after successful AF cardioversion reported sig-
nificant changes in several measurements of LA
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size within 7 weeks [6]. The discrepancy of those
results might be explained by differences in study
samples, the shorter long-term follow-up period
used in this study, and the fact that more than half
of the cases already had normal LA size 24 hr after
cardioversion.
In the present study, HR during echocardiog-
raphy was considered normal. No differences were
detected between treatment groups while HR
decreased slightly with increasing time after
treatment. Recently, we showed that mildly ele-
vated HR up to 50 beats per minute did not have a
recognizable effect on the feasibility of 2DST
analyses, whereas HR was positively correlated
with SL and SRL during atrial active contraction
phase [20]. Hence, the slight decrease in HR over
time might have counteracted, to a small degree,
the increases in SL and SRL observed in this study.
Besides the intrinsic limitations of speckle
tracking echocardiography as described previously
[20], this study has further limitations. One limi-
tation is that 2DST analyses were not performed
before cardioversion, which might be useful for
prognostication of success of cardioversion and AF
recurrence as demonstrated in people [21]. The
limiting factor was that 2DST in horses was estab-
lished using a P wave trigger rather than a R wave
trigger to define the onset of SL and SRL [20]. While
the P wave trigger is physiologically more appro-
priate to quantify atrial contractile function and is
recommended to be given priority over the R wave
trigger method for patients in sinus rhythm [47],
analyses using the P wave trigger cannot be per-
formed in patients with AF.
A second limitation is that the number of cases
included in this study was small and that cases in
the treatment groups were not matched regarding
age, BWT and sex. Further limitations include that
measurements were not performed blinded to
time of examination or horse identity and that the
influence of duration of AF, the number and total
energy of electrical shocks, the total dose of QS
and underlying structural diseases were not taken
into consideration. Sotalol and quinapril were
administered to some horses after cardioversion.
Owing to the small sample size, the potential
effect of this supplementary medication on atrial
mechanical function was not investigated. How-
ever, because this was a proof-of-concept study
for the use of 2DST for detection of LA mechanical
dysfunction, the influence of additional drug
treatment on LA mechanical function was not a
primary research question.
Echocardiographic images were obtained using
two different ultrasound systems, a GE Vivid 7
echocardiograph with a M4S probe and a GE Vivid
e95 echocardiograph with a 4Vc-D probe, with the
Vivid 7 used primarily for QS cases. While newer
generation ultrasound systems were shown to
produce better quality images than older systems
[48], information regarding the potential impact of
ultrasound systems on speckle tracking analyses is
scarce. One study comparing two different ultra-
sound systems and speckle tracking software by
different manufactures found comparable results
for assessment of ventricular myocardial function,
with global longitudinal strain being the most
robust variable [49]. However, no data are avail-
able regarding different generations of ultrasound
systems of the same manufacturer. In this study,
every effort was made to obtain high quality,
standardized images at appropriate frame rates
regardless of ultrasound system used. Sub-
jectively, 2D image quality did not differ to a
marked extent. Most importantly, all 2DST analyses
were performed batchwise for the purpose of this
study using the same EchoPAC softwareb version,
therefore excluding possible influence of varying
2DST algorithms.
Conclusions
In conclusion, the results of this study provide
proof-of-concept for using 2DST-derived global SL
and SRL to diagnose atrial contractile dysfunction
in horses with AF after successful cardioversion to
NSR. To investigate the clinical value of 2DST
variables to predict AF recurrence and identify the
variables with the highest prognostic value, larger
studies with long-term follow-up of all cases are
necessary.
Conflict of interest statement
The authors do not have any conflicts of interest
to disclose.
References
[1] Reef VB, Bonagura J, Buhl R, McGurrin MK,
Schwarzwald CC, van Loon G, Young LE. Recommendations
for management of equine athletes with cardiovascular
abnormalities. J Vet Intern Med 2014;28:749e61.
[2] van Loon G. Cardiac arrhythmias in horses. Vet Clin N Am
Equine Pract 2019;35:85e102.
[3] Hesselkilde EZ, Carstensen H, Flethoj M, Fenner M,
Kruse DD, Sattler SM, Tfelt-Hansen J, Pehrson S,
Braunstein TH, Carlson J, Platonov PG, Jespersen T,
Buhl R. Longitudinal study of electrical, functional and
structural remodelling in an equine model of atrial fibril-
lation. BMC Cardiovasc Disord 2019;19:228.
118 C. Eberhardt, C.C. Schwarzwald
[4] Schwarzwald CC, Schober KE, Bonagura JD. Echocardio-
graphic evidence of left atrial mechanical dysfunction
after conversion of atrial fibrillation to sinus rhythm in 5
horses. J Vet Intern Med 2007;21:820e7.
[5] De Clercq D, van Loon G, Tavernier R, Duchateau L,
Deprez P. Atrial and ventricular electrical and contractile
remodeling and reverse remodeling owing to short-term
pacing-induced atrial fibrillation in horses. J Vet Intern
Med 2008;22:1353e9.
[6] Decloedt A, Verheyen T, Van Der Vekens N, Sys S, De
Clercq D, van Loon G. Long-term follow-up of atrial func-
tion after cardioversion of atrial fibrillation in horses. Vet J
2013;197:583e8.
[7] Schwarzwald CC, Schober KE, Bonagura JD. Methods and
reliability of echocardiographic assessment of left atrial
size and mechanical function in horses. Am J Vet Res 2007;
68:735e47.
[8] Huesler IM, Mitchell KJ, Schwarzwald CC. Echocardio-
graphic assessment of left atrial size and function in
Warmblood horses: reference intervals, allometric scaling,
and agreement of different echocardiographic variables. J
Vet Intern Med 2016;30:1241e52.
[9] Schwarzwald CC. Equine echocardiography. Vet Clin N Am
Equine Pract 2019;35:43e64.
[10] Decloedt A, Schwarzwald CC, De Clercq D, Van Der
Vekens N, Pardon B, Reef VB, van Loon G. Risk factors for
recurrence of atrial fibrillation in horses after car-
dioversion to sinus rhythm. J Vet Intern Med 2015;29:
946e53.
[11] Cameli M, Caputo M, Mondillo S, Ballo P, Palmerini E,
Lisi M, Marino E, Galderisi M. Feasibility and reference
values of left atrial longitudinal strain imaging by two-
dimensional speckle tracking. Cardiovasc Ultrasound
2009;7:6.
[12] Cianciulli TF, Saccheri MC, Lax JA, Bermann AM,
Ferreiro DE. Two-dimensional speckle tracking echo-
cardiography for the assessment of atrial function. World J
Cardiol 2010;2:163e70.
[13] Kim DG, Lee KJ, Lee S, Jeong SY, Lee YS, Choi YJ, Yoon HS,
Kim JH, Jeong KT, Park SC, Park M. Feasibility of two-
dimensional global longitudinal strain and strain rate
imaging for the assessment of left atrial function: a study
in subjects with a low probability of cardiovascular disease
and normal exercise capacity. Echocardiography 2009;26:
1179e87.
[14] Schwarzwald CC, Schober KE, Berli AS, Bonagura JD. Left
ventricular radial and circumferential wall motion analysis
in horses using strain, strain rate, and displacement by 2D
speckle tracking. J Vet Intern Med 2009;23:890e900.
[15] Decloedt A, Verheyen T, Sys S, De Clercq D, van Loon G.
Quantification of left ventricular longitudinal strain, strain
rate, velocity, and displacement in healthy horses by 2-
dimensional speckle tracking. J Vet Intern Med 2011;25:
330e8.
[16] Decloedt A, De Clercq D, Ven Sofie S, Van Der Vekens N,
Sys S, Broux B, van Loon G. Echocardiographic measure-
ments of right heart size and function in healthy horses.
Equine Vet J 2017;49:58e64.
[17] Schefer KD, Hagen R, Ringer SK, Schwarzwald CC. Labo-
ratory, electrocardiographic, and echocardiographic
detection of myocardial damage and dysfunction in an
Arabian mare with nutritional masseter myodegeneration.
J Vet Intern Med 2011;25:1171e80.
[18] Decloedt A, Borowicz H, Slowikowska M, Chiers K, van
Loon G, Niedzwiedz A. Right ventricular function during
acute exacerbation of severe equine asthma. Equine Vet J
2017;49:603e8.
[19] Decloedt A, Verheyen T, Sys S, De Clercq D, van Loon G.
Tissue Doppler imaging and 2-dimensional speckle tracking
of left ventricular function in horses exposed to lasalocid.
J Vet Intern Med 2012;26:1209e16.
[20] Eberhardt C, Mitchell KJ, Schwarzwald CC. Quantification
of left atrial wall motion in healthy horses using two-
dimensional speckle tracking. J Vet Cardiol 2020;30:
32e43.
[21] Cameli M, Mandoli GE, Loiacono F, Sparla S, Iardino E,
Mondillo S. Left atrial strain: a useful index in atrial
fibrillation. Int J Cardiol 2016;220:208e13.
[22] Moreno-Ruiz LA, Madrid-Miller A, Martinez-Flores JE,
Gonzalez-Hermosillo JA, Arenas-Fonseca J, Zamorano-
Velazquez N, Mendoza-Perez B. Left atrial longitudinal
strain by speckle tracking as independent predictor of
recurrence after electrical cardioversion in persistent and
long standing persistent non-valvular atrial fibrillation. Int
J Cardiovasc Imag 2019;35:1587e96.
[23] Parwani AS, Morris DA, Blaschke F, Huemer M, Pieske B,
Haverkamp W, Boldt LH. Left atrial strain predicts recur-
rence of atrial arrhythmias after catheter ablation of
persistent atrial fibrillation. Open heart 2017;4:e000572.
[24] Ma XX, Zhang YL, Hu B, Zhu MR, Jiang WJ, Wang M,
Zheng DY, Xue XP. The usefulness of global left atrial strain
for predicting atrial fibrillation recurrence after catheter
ablation in patients with persistent and paroxysmal atrial
fibrillation. Arch Cardiovasc Dis 2017;110:447e55.
[25] Landis JR, Koch GG. The measurement of observer
agreement for categorical data. Biometrics 1977;33:
159e74.
[26] Blessberger H, Binder T. NON-invasive imaging: two
dimensional speckle tracking echocardiography: basic
principles. Heart 2010;96:716e22.
[27] Abraham TP, Dimaano VL, Liang HY. Role of tissue Doppler
and strain echocardiography in current clinical practice.
Circulation 2007;116:2597e609.
[28] Buggey J, Hoit BD. Left atrial strain: measurement and
clinical application. Curr Opin Cardiol 2018;33:479e85.
[29] Cameli M, Mandoli GE, Lisi E, Ibrahim A, Incampo E,
Buccoliero G, Rizzo C, Devito F, Ciccone MM, Mondillo S.
Left atrial, ventricular and atrio-ventricular strain in
patients with subclinical heart dysfunction. Int J Car-
diovasc Imag 2019;35:249e58.
[30] Cameli M, Pastore MC, Righini FM, Mandoli GE, D’Ascenzi F,
Lisi M, Nistor D, Sparla S, Curci V, Di Tommaso C, Marino F,
Stricagnoli M, Mondillo S. Prognostic value of left atrial
strain in patients with moderate asymptomatic mitral
regurgitation. Int J Cardiovasc Imag 2019;35:1597e604.
[31] Mandoli GE, Sisti N, Mondillo S, Cameli M. Left atrial strain
in left ventricular diastolic dysfunction: have we finally
found the missing piece of the puzzle? Heart Fail Rev 2020;
25:409e17.
[32] Caivano D, Rishniw M, Birettoni F, Patata V, Giorgi ME,
Porciello F. Left atrial deformation and phasic function
determined by two-dimensional speckle-tracking echo-
cardiography in dogs with myxomatous mitral valve dis-
ease. J Vet Cardiol 2018;20:102e14.
[33] Nakamura K, Kawamoto S, Osuga T, Morita T, Sasaki N,
Morishita K, Ohta H, Takiguchi M. Left atrial strain at dif-
ferent stages of myxomatous mitral valve disease in dogs.
J Vet Intern Med 2017;31:316e25.
[34] Goldberg A, Kusunose K, Qamruddin S, Rodriguez LL,
Mazgalev TN, Griffin BP, Van Wagoner DR, Zhang Y,
Popovic ZB. Left atrial size and function in a canine model
of chronic atrial fibrillation and heart failure. PLoS One
2016;11:e0147015.
Left atrial function by speckle tracking in horses 119
[35] Baron Toaldo M, Romito G, Guglielmini C, Diana A,
Pelle NG, Contiero B, Cipone M. Prognostic value of
echocardiographic indices of left atrial morphology and
function in dogs with myxomatous mitral valve disease. J
Vet Intern Med 2018;32:914e21.
[36] Gan GCH, Ferkh A, Boyd A, Thomas L. Left atrial function:
evaluation by strain analysis. Cardiovasc Diagn Ther 2018;
8:29e46.
[37] Hayashi S, Yamada H, Bando M, Saijo Y, Nishio S, Hirata Y,
Klein AL, Sata M. Optimal analysis of left atrial strain by
speckle tracking echocardiography: P-wave versus R-wave
trigger. Echocardiography 2015;32:1241e9.
[38] De Clercq D, Decloedt A, Sys SU, Verheyen T, Van Der
Vekens N, van Loon G. Atrial fibrillation cycle length and
atrial size in horses with and without recurrence of atrial
fibrillation after electrical cardioversion. J Vet Intern Med
2014;28:624e9.
[39] Aizer A, Gaziano JM, Cook NR, Manson JE, Buring JE,
Albert CM. Relation of vigorous exercise to risk of atrial
fibrillation. Am J Cardiol 2009;103:1572e7.
[40] Sideris DA, Toumanidis ST, Tselepatiotis E, Kostopoulos K,
Stringli T, Kitsiou T, Moulopoulos SD. Atrial pressure and
experimental atrial fibrillation. Pacing Clin Electrophysiol
1995;18:1679e85.
[41] Kuppahally SS, Akoum N, Burgon NS, Badger TJ,
Kholmovski EG, Vijayakumar S, Rao SN, Blauer J, Fish EN,
Dibella EV, Macleod RS, McGann C, Litwin SE,
Marrouche NF. Left atrial strain and strain rate in patients
with paroxysmal and persistent atrial fibrillation: rela-
tionship to left atrial structural remodeling detected by
delayed-enhancement MRI. Circ Cardiovasc Imaging 2010;
3:231e9.
[42] Pagel PS, Kehl F, Gare M, Hettrick DA, Kersten JR,
Warltier DC. Mechanical function of the left atrium: new
insights based on analysis of pressure-volume relations and
Doppler echocardiography. Anesthesiology 2003;98:
975e94.
[43] Harjai KJ, Mobarek SK, Cheirif J, Boulos LM, Murgo JP, Abi-
Samra F. Clinical variables affecting recovery of left atrial
mechanical function after cardioversion from atrial fibril-
lation. J Am Coll Cardiol 1997;30:481e6.
[44] McGurrin MK, Physick-Sheard PW, Kenney DG. How to
perform transvenous electrical cardioversion in horses
with atrial fibrillation. J Vet Cardiol 2005;7:109e19.
[45] McGurrin MK, Physick-Sheard PW, Kenney DG. Transvenous
electrical cardioversion of equine atrial fibrillation:
patient factors and clinical results in 72 treatment epi-
sodes. J Vet Intern Med 2008;22:609e15.
[46] McGurrin MKJ. The diagnosis and management of atrial
fibrillation in the horse. Vet Med 2015;6:83e90.
[47] Donal E, Lip GY, Galderisi M, Goette A, Shah D, Marwan M,
Lederlin M, Mondillo S, Edvardsen T, Sitges M, Grapsa J,
Garbi M, Senior R, Gimelli A, Potpara TS, Van Gelder IC,
Gorenek B, Mabo P, Lancellotti P, Kuck KH, Popescu BA,
Hindricks G, Habib G, Cardim NM, Cosyns B, Delgado V,
Haugaa KH, Muraru D, Nieman K, Boriani G, Cohen A.
EACVI/EHRA Expert Consensus Document on the role of
multi-modality imaging for the evaluation of patients with
atrial fibrillation. Eur Heart J Cardiovasc Imaging 2016;17:
355e83.
[48] Nagata Y, Kado Y, Onoue T, Otani K, Nakazono A, Otsuji Y,
Takeuchi M. Impact of image quality on reliability of the
measurements of left ventricular systolic function and
global longitudinal strain in 2D echocardiography. Echo Res
Pract 2018;5:27e39.
[49] Manovel A, Dawson D, Smith B, Nihoyannopoulos P.
Assessment of left ventricular function by different
speckle-tracking software. Eur J Echocardiogr 2010;11:
417e21.
Available online at www.sciencedirect.com
ScienceDirect
120 C. Eberhardt, C.C. Schwarzwald
